Treatment Study for Patients with Glioblastoma

Testing the use of the immunotherapy drugs ipilimumab and nivolumab plus radiation therapy compared to the usual treatment (temozolomide and radiation therapy) for newly diagnosed MGMT unmethylated Glioblastoma

Glioblastoma brain cancer, CT scan
AGE: ≥ 18 years old
TYPE: Interventional Study
CONDITION: Glioblastoma
LOCATION: UH Cleveland Medical Center or Virtual

Learn More About This Research Study

Please call 1-800-641-2422 for more information or complete the online form below.

Study Purpose

The purpose of this study is to compare the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy with ipilimumab and nivolumab in treating patients with newly diagnosed MGMT unmethylated glioblastoma.

Who Can Participate

Participants 18 years of age and older who are diagnosed with may be eligible for this study.

To learn more about this study, please fill out the form below to request more information.

Study ID

Principal Investigator: Bryan Bonder, MD

Bryan Bonder